Individuals enrolled in Apple Health (Medicaid), Public Employees Benefits Board, and School Employees Benefits Board coverage - and those accessing behavioral health services - will not experience a disruption in care due to the federal government shutdown. In addition, health care providers will continue to be paid for the services they provide. We will continue to monitor the situation closely and share updates if anything changes.
The following resources are for reporting entities who may need assistance with prescription drug price transparency.
Want to stay up-to-date on prescription drug price transparency?
The following resources are for reporting entities who may need assistance.
The excel templates below are available as an aid if you are hand-keying data for submissions to the Drug Price Transparency program. These workbooks are programmed with simple rules that will help you avoid some common errors that can occur.
Important note about Excel version
We recommend using Microsoft Excel 2016 or earlier for the submission guides. Using Microsoft Excel 2019 can cause formatting issues when saving as a CSV file.
Starting November 15, reporting entities can log into HCA Support to enter their data for the DPT program. You will need a SecureAccess Washington (SAW) account to login.
Use the extension form if you are not able to meet the due date of a required report and would like to request additional time. To access the extension form, follow the instructions for accessing DPT reporting forms. Once you have accessed the portal, you will see the DPT re-submission/extension option.
At each meeting, HCA will give a short overview of Chapter 43.71C RCW then use the majority of time to take questions and hear concerns from stakeholders. We will focus on a different supplier in each meeting. The public is invited to participate in any of the meetings.
| Date and time | Meeting type | Materials |
|---|---|---|
| July 28, 2021 | PBM listening session | |
| July 22, 2021 | Manufacturer listening session | |
| July 6, 2021 | Carrier listening session | |
| April 29, 2020 |
Pharmacy benefit manager / pharmacy service administrative organization reporting Webinar only, no in person meeting due to COVID-19 |
|
| April 1, 2020 |
Issuer / carrier reporting Webinar only, no in person meeting due to COVID-19 |
Updated slide deck |
| February 26, 2020 | Manufacturer reporting |
In 2019, the Washington State Legislature passed Engrossed Second Substitute House Bill into law. This law requires issuers of health insurance, pharmacy benefit managers (PBMs), manufacturers, and pharmacy service administrative organizations (PSAOs) to submit data to the Health Care Authority (HCA). The purpose is to create an annual report on how prescription drugs affect health care costs. The law also requires pharmaceutical manufacturers to submit data to HCA relating the new drug applications (NDA).
Annual reports created by HCA to detail the current state of the program as the agency begins to receive drug pricing and cost data.
Program questions and information
Email: HCA Drug Price Transparency - general inquiry
Technical data related questions, or any questions regarding the data submission process
Email: HCA Drug Price Transparency - tech support
Protections for insurance consumers and insurance industry oversight
Contact: Washington State Office of the Insurance Commissioner (OIC)